1. Home
  2. ALZN vs LXEH Comparison

ALZN vs LXEH Comparison

Compare ALZN & LXEH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALZN
  • LXEH
  • Stock Information
  • Founded
  • ALZN 2016
  • LXEH 2001
  • Country
  • ALZN United States
  • LXEH China
  • Employees
  • ALZN N/A
  • LXEH N/A
  • Industry
  • ALZN Medicinal Chemicals and Botanical Products
  • LXEH Other Consumer Services
  • Sector
  • ALZN Health Care
  • LXEH Real Estate
  • Exchange
  • ALZN Nasdaq
  • LXEH Nasdaq
  • Market Cap
  • ALZN 6.1M
  • LXEH 10.5M
  • IPO Year
  • ALZN 2021
  • LXEH 2020
  • Fundamental
  • Price
  • ALZN $0.69
  • LXEH $9.30
  • Analyst Decision
  • ALZN Strong Buy
  • LXEH
  • Analyst Count
  • ALZN 1
  • LXEH 0
  • Target Price
  • ALZN $32.00
  • LXEH N/A
  • AVG Volume (30 Days)
  • ALZN 869.9K
  • LXEH 9.3K
  • Earning Date
  • ALZN 03-10-2025
  • LXEH 03-24-2025
  • Dividend Yield
  • ALZN N/A
  • LXEH N/A
  • EPS Growth
  • ALZN N/A
  • LXEH N/A
  • EPS
  • ALZN N/A
  • LXEH N/A
  • Revenue
  • ALZN N/A
  • LXEH $5,628,870.00
  • Revenue This Year
  • ALZN N/A
  • LXEH N/A
  • Revenue Next Year
  • ALZN N/A
  • LXEH N/A
  • P/E Ratio
  • ALZN N/A
  • LXEH N/A
  • Revenue Growth
  • ALZN N/A
  • LXEH N/A
  • 52 Week Low
  • ALZN $0.66
  • LXEH $1.95
  • 52 Week High
  • ALZN $15.06
  • LXEH $63.00
  • Technical
  • Relative Strength Index (RSI)
  • ALZN 24.21
  • LXEH 64.24
  • Support Level
  • ALZN $0.66
  • LXEH $8.90
  • Resistance Level
  • ALZN $0.93
  • LXEH $9.37
  • Average True Range (ATR)
  • ALZN 0.07
  • LXEH 0.49
  • MACD
  • ALZN -0.01
  • LXEH -0.14
  • Stochastic Oscillator
  • ALZN 9.00
  • LXEH 92.86

About ALZN Alzamend Neuro Inc.

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.

About LXEH Lixiang Education Holding Co. Ltd.

Lixiang Education Holding Co Ltd is a private primary and secondary education service provider in Lishui City, Zhejiang Province. Its private education services primarily include primary and middle school education from grade 1 to grade 9. The company also offers high school education services at its High School Divisions.

Share on Social Networks: